BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu LN, Xu HX, Zhang YF, Xu JM. Hepatocellular carcinoma after ablation: The imaging follow-up scheme. World J Gastroenterol 2013; 19(6): 797-801 [PMID: 23429970 DOI: 10.3748/wjg.v19.i6.797]
URL: https://www.wjgnet.com/2307-8960/full/v19/i6/797.htm
Number Citing Articles
1
Sanjay Bansal, Jonathan Gui, Christina Merrill, Jason K. Wong, Kelly W. Burak, Stephanie R. Wilson. Contrast-enhanced US in Local Ablative Therapy and Secondary Surveillance for Hepatocellular CarcinomaRadioGraphics 2019; 39(5): 1302 doi: 10.1148/rg.2019180205
2
Si-Min Ruan, Mei-Qing Cheng, Hui Huang, Hang-Tong Hu, Wei Li, Xiao-Yan Xie, Ming-De Lu, Ming Kuang, Man-Xia Lin, Wei Wang. Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility StudyJournal of Hepatocellular Carcinoma 2022; : 437 doi: 10.2147/JHC.S353914
3
Yi Gao, Dong-Yan Zheng, Zheng Cui, Yan Ma, Yuan-Zhi Liu, Wei Zhang. Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablationWorld Journal of Gastroenterology 2015; 21(36): 10418-10426 doi: 10.3748/wjg.v21.i36.10418
4
Jeanne M. Horowitz, Ihab R. Kamel, Hina Arif-Tiwari, Sumeet K. Asrani, Nicole M. Hindman, Harmeet Kaur, Michelle M. McNamara, Richard B. Noto, Aliya Qayyum, Tasneem Lalani. ACR Appropriateness Criteria ® Chronic Liver DiseaseJournal of the American College of Radiology 2017; 14(5): S103 doi: 10.1016/j.jacr.2017.02.011
5
Jin-Yu Wu, Xiu-Mei Bai, Hong Wang, Qian Xu, Song Wang, Wei Wu, Kun Yan, Wei Yang. The Perfusion Features of Recurrent Hepatocellular Carcinoma After Radiofrequency Ablation Using Contrast-Enhanced Ultrasound and Pathological Stemness Evaluation: Compared to Initial TumorsFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01464
6
Davide Roccarina, Matteo Garcovich, Maria Elena Ainora, Laura Riccardi, Maurizio Pompili, Antonio Gasbarrini, Maria Assunta Zocco. Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatmentWorld Journal of Hepatology 2015; 7(14): 1866-1874 doi: 10.4254/wjh.v7.i14.1866
7
Orlando Catalano, Francesco Izzo, Paolo Vallone, Fabio Sandomenico, Vittorio Albino, Antonio Nunziata, Roberta Fusco, Antonella Petrillo. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experienceActa Radiologica 2015; 56(2): 133 doi: 10.1177/0284185114521108
8
Xiaoer Zhang, Guangliang Huang, Jieyi Ye, Ming Xu, Longfei Cong, Xujin He, Tongyi Huang, Ming Kuang, Xiaoyan Xie. 3-D Contrast-Enhanced Ultrasound Fusion Imaging: A New Technique to Evaluate the Ablative Margin of Radiofrequency Ablation for Hepatocellular CarcinomaUltrasound in Medicine & Biology 2019; 45(8): 1933 doi: 10.1016/j.ultrasmedbio.2019.03.019
9
Li-Yue Sun, Zi-Ming Du, Yu-Ying Liu, Yan-Hong Li, Xiao-Min Liu, Ting Wang, Jian-Yong Shao. Diagnostic and Prognostic Characteristics of Circulating Free DNA Methylation Detected by the Electrochemical Method in Malignant TumorsCancers 2021; 13(4): 664 doi: 10.3390/cancers13040664
10
Shu-Guang Zheng, Hui-Xiong Xu, Lin-Na Liu. Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasoundWorld Journal of Radiology 2014; 6(1): 7-14 doi: 10.4329/wjr.v6.i1.7
11
Jeanne M. Horowitz, Ihab R. Kamel, Hina Arif-Tiwari, Sumeet K. Asrani, Nicole M. Hindman, Harmeet Kaur, Michelle M. McNamara, Richard B. Noto, Aliya Qayyum, Tasneem Lalani. ACR Appropriateness Criteria ® Chronic Liver DiseaseJournal of the American College of Radiology 2017; 14(11): S391 doi: 10.1016/j.jacr.2017.08.045
12
Li-Yue Sun, Qing Ouyang, Wen-Jian Cen, Fang Wang, Wen-Ting Tang, Jian-Yong Shao. A Model Based on Artificial Intelligence Algorithm for Monitoring Recurrence of HCC after HepatectomyThe American Surgeon™ 2023; 89(5): 1468 doi: 10.1177/00031348211063549